Neuropathy / diabetic peripheral neuropathy
Photobiomodulation for diabetic peripheral neuropathy systematic review
Korada HY, Arora E, Maiya GA, et al. Current Diabetes Reviews. 2023.
A systematic review found PBM studies reporting improvements in neuropathic pain, nerve conduction, and plantar pressure distribution.
Evidence grade
low
Effect direction
positive
Panel relevance
partially-replicable
Key findings
- The review included eight randomized and non-randomized studies.
- Included studies reported improved neuropathic pain and nerve conduction velocity.
- The authors also reported reduced plantar pressure distribution, a risk factor related to diabetic foot ulcers.
Protocol details
| Wavelengths | Not reported nm |
|---|---|
| Irradiance | Not reported mW/cm2 |
| Fluence | Not reported J/cm2 |
| Session time | Not reported minutes |
| Frequency | Varied by study |
| Duration | Varied by study |
| Treatment area | Feet or lower limb targets in diabetic peripheral neuropathy |
| Device type | Photobiomodulation therapy devices |
Caveats
- Evidence includes non-randomized studies, lowering certainty.
- Diabetic neuropathy is a medical condition and should not be treated with panels without clinical supervision.